The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Anti Rabies Serum Market Research Report 2024

Global Anti Rabies Serum Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1747790

No of Pages : 90

Synopsis
Global Anti Rabies Serum market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti Rabies Serum market research.
Anti-rabies serum is a biological product that is used to prevent and treat rabies infection. It is made from the blood of animals that have been immunized against the rabies virus. The serum contains antibodies that can neutralize the virus and prevent it from causing disease.

The development prospects of anti-rabies serum are promising. Advances in biotechnology and immunology have led to the development of new techniques for producing and purifying antibodies. These techniques have made it possible to produce high-quality anti-rabies serum that is safe and effective.

In addition, there is a growing demand for anti-rabies serum in many parts of the world, particularly in developing countries where rabies is still a major public health problem. This demand has led to increased investment in research and development of new anti-rabies serum products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anti Rabies Serum market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Haffkine Ajintha Pharmaceuticals
Bharat Serums and Vaccines
National Institutes of Health
Congruent Pharmachem
Shanghai Serum Bio-technology
Serum Institute of India
Premium Serums
LEXICARE PHARMA
Zydus Cadila Healthcare
VINS Bio-Products
Zydus Takeda Healthcare
BPL
Aventis Pasteur
Segment by Type
Human Anti-rabies Immunoglobulin
Equine Anti-rabies Immunoglobulin
Segment by Application
Clinic
Hospital
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Anti Rabies Serum report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Anti Rabies Serum Market Overview
1.1 Product Overview and Scope of Anti Rabies Serum
1.2 Anti Rabies Serum Segment by Type
1.2.1 Global Anti Rabies Serum Market Value Comparison by Type (2023-2029)
1.2.2 Human Anti-rabies Immunoglobulin
1.2.3 Equine Anti-rabies Immunoglobulin
1.3 Anti Rabies Serum Segment by Application
1.3.1 Global Anti Rabies Serum Market Value by Application: (2023-2029)
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Anti Rabies Serum Market Size Estimates and Forecasts
1.4.1 Global Anti Rabies Serum Revenue 2018-2029
1.4.2 Global Anti Rabies Serum Sales 2018-2029
1.4.3 Global Anti Rabies Serum Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti Rabies Serum Market Competition by Manufacturers
2.1 Global Anti Rabies Serum Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti Rabies Serum Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti Rabies Serum Average Price by Manufacturers (2018-2023)
2.4 Global Anti Rabies Serum Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti Rabies Serum, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti Rabies Serum, Product Type & Application
2.7 Anti Rabies Serum Market Competitive Situation and Trends
2.7.1 Anti Rabies Serum Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti Rabies Serum Players Market Share by Revenue
2.7.3 Global Anti Rabies Serum Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti Rabies Serum Retrospective Market Scenario by Region
3.1 Global Anti Rabies Serum Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti Rabies Serum Global Anti Rabies Serum Sales by Region: 2018-2029
3.2.1 Global Anti Rabies Serum Sales by Region: 2018-2023
3.2.2 Global Anti Rabies Serum Sales by Region: 2024-2029
3.3 Global Anti Rabies Serum Global Anti Rabies Serum Revenue by Region: 2018-2029
3.3.1 Global Anti Rabies Serum Revenue by Region: 2018-2023
3.3.2 Global Anti Rabies Serum Revenue by Region: 2024-2029
3.4 North America Anti Rabies Serum Market Facts & Figures by Country
3.4.1 North America Anti Rabies Serum Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti Rabies Serum Sales by Country (2018-2029)
3.4.3 North America Anti Rabies Serum Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti Rabies Serum Market Facts & Figures by Country
3.5.1 Europe Anti Rabies Serum Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti Rabies Serum Sales by Country (2018-2029)
3.5.3 Europe Anti Rabies Serum Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti Rabies Serum Market Facts & Figures by Country
3.6.1 Asia Pacific Anti Rabies Serum Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti Rabies Serum Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti Rabies Serum Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti Rabies Serum Market Facts & Figures by Country
3.7.1 Latin America Anti Rabies Serum Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti Rabies Serum Sales by Country (2018-2029)
3.7.3 Latin America Anti Rabies Serum Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti Rabies Serum Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti Rabies Serum Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti Rabies Serum Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti Rabies Serum Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti Rabies Serum Sales by Type (2018-2029)
4.1.1 Global Anti Rabies Serum Sales by Type (2018-2023)
4.1.2 Global Anti Rabies Serum Sales by Type (2024-2029)
4.1.3 Global Anti Rabies Serum Sales Market Share by Type (2018-2029)
4.2 Global Anti Rabies Serum Revenue by Type (2018-2029)
4.2.1 Global Anti Rabies Serum Revenue by Type (2018-2023)
4.2.2 Global Anti Rabies Serum Revenue by Type (2024-2029)
4.2.3 Global Anti Rabies Serum Revenue Market Share by Type (2018-2029)
4.3 Global Anti Rabies Serum Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti Rabies Serum Sales by Application (2018-2029)
5.1.1 Global Anti Rabies Serum Sales by Application (2018-2023)
5.1.2 Global Anti Rabies Serum Sales by Application (2024-2029)
5.1.3 Global Anti Rabies Serum Sales Market Share by Application (2018-2029)
5.2 Global Anti Rabies Serum Revenue by Application (2018-2029)
5.2.1 Global Anti Rabies Serum Revenue by Application (2018-2023)
5.2.2 Global Anti Rabies Serum Revenue by Application (2024-2029)
5.2.3 Global Anti Rabies Serum Revenue Market Share by Application (2018-2029)
5.3 Global Anti Rabies Serum Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Haffkine Ajintha Pharmaceuticals
6.1.1 Haffkine Ajintha Pharmaceuticals Corporation Information
6.1.2 Haffkine Ajintha Pharmaceuticals Description and Business Overview
6.1.3 Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Haffkine Ajintha Pharmaceuticals Anti Rabies Serum Product Portfolio
6.1.5 Haffkine Ajintha Pharmaceuticals Recent Developments/Updates
6.2 Bharat Serums and Vaccines
6.2.1 Bharat Serums and Vaccines Corporation Information
6.2.2 Bharat Serums and Vaccines Description and Business Overview
6.2.3 Bharat Serums and Vaccines Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bharat Serums and Vaccines Anti Rabies Serum Product Portfolio
6.2.5 Bharat Serums and Vaccines Recent Developments/Updates
6.3 National Institutes of Health
6.3.1 National Institutes of Health Corporation Information
6.3.2 National Institutes of Health Description and Business Overview
6.3.3 National Institutes of Health Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.3.4 National Institutes of Health Anti Rabies Serum Product Portfolio
6.3.5 National Institutes of Health Recent Developments/Updates
6.4 Congruent Pharmachem
6.4.1 Congruent Pharmachem Corporation Information
6.4.2 Congruent Pharmachem Description and Business Overview
6.4.3 Congruent Pharmachem Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Congruent Pharmachem Anti Rabies Serum Product Portfolio
6.4.5 Congruent Pharmachem Recent Developments/Updates
6.5 Shanghai Serum Bio-technology
6.5.1 Shanghai Serum Bio-technology Corporation Information
6.5.2 Shanghai Serum Bio-technology Description and Business Overview
6.5.3 Shanghai Serum Bio-technology Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Shanghai Serum Bio-technology Anti Rabies Serum Product Portfolio
6.5.5 Shanghai Serum Bio-technology Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Serum Institute of India Anti Rabies Serum Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 Premium Serums
6.6.1 Premium Serums Corporation Information
6.6.2 Premium Serums Description and Business Overview
6.6.3 Premium Serums Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Premium Serums Anti Rabies Serum Product Portfolio
6.7.5 Premium Serums Recent Developments/Updates
6.8 LEXICARE PHARMA
6.8.1 LEXICARE PHARMA Corporation Information
6.8.2 LEXICARE PHARMA Description and Business Overview
6.8.3 LEXICARE PHARMA Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.8.4 LEXICARE PHARMA Anti Rabies Serum Product Portfolio
6.8.5 LEXICARE PHARMA Recent Developments/Updates
6.9 Zydus Cadila Healthcare
6.9.1 Zydus Cadila Healthcare Corporation Information
6.9.2 Zydus Cadila Healthcare Description and Business Overview
6.9.3 Zydus Cadila Healthcare Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zydus Cadila Healthcare Anti Rabies Serum Product Portfolio
6.9.5 Zydus Cadila Healthcare Recent Developments/Updates
6.10 VINS Bio-Products
6.10.1 VINS Bio-Products Corporation Information
6.10.2 VINS Bio-Products Description and Business Overview
6.10.3 VINS Bio-Products Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.10.4 VINS Bio-Products Anti Rabies Serum Product Portfolio
6.10.5 VINS Bio-Products Recent Developments/Updates
6.11 Zydus Takeda Healthcare
6.11.1 Zydus Takeda Healthcare Corporation Information
6.11.2 Zydus Takeda Healthcare Anti Rabies Serum Description and Business Overview
6.11.3 Zydus Takeda Healthcare Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zydus Takeda Healthcare Anti Rabies Serum Product Portfolio
6.11.5 Zydus Takeda Healthcare Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Anti Rabies Serum Description and Business Overview
6.12.3 BPL Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BPL Anti Rabies Serum Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Aventis Pasteur
6.13.1 Aventis Pasteur Corporation Information
6.13.2 Aventis Pasteur Anti Rabies Serum Description and Business Overview
6.13.3 Aventis Pasteur Anti Rabies Serum Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Aventis Pasteur Anti Rabies Serum Product Portfolio
6.13.5 Aventis Pasteur Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti Rabies Serum Industry Chain Analysis
7.2 Anti Rabies Serum Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti Rabies Serum Production Mode & Process
7.4 Anti Rabies Serum Sales and Marketing
7.4.1 Anti Rabies Serum Sales Channels
7.4.2 Anti Rabies Serum Distributors
7.5 Anti Rabies Serum Customers
8 Anti Rabies Serum Market Dynamics
8.1 Anti Rabies Serum Industry Trends
8.2 Anti Rabies Serum Market Drivers
8.3 Anti Rabies Serum Market Challenges
8.4 Anti Rabies Serum Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’